Willett Advisors key facts
- Willett Advisors is a family office based in New York, New York with 6 tracked portfolio companies.
- Notable positions include Neurona Therapeutics, Cellares, Antares Therapeutics.
- The team roster lists 4 people.
Willett Advisors portfolio at a glance
6 portfolio companies are on record for Willett Advisors, including Neurona Therapeutics, Cellares and Antares Therapeutics.
5 of the 6 carry a recorded valuation.
Willett Advisors team
4 people are on record at Willett Advisors: 2 partners and 2 principals. Senior names include Andrew Mulderry (Co-Chief Investment Officer), Steven Rattner (Chief Executive Officer) and Neil Shah (Managing Director). 4 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 6 recorded positions
- ·Watchlist + alerts for Willett Advisors's activity
Portfolio
6 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Neurona Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
| Cellares | — | ▮ | ▮ | ▮ |
| Antares Therapeutics | — | ▮ | ▮ | ▮ |
+ 3 more companies · all 6, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Willett Advisors
- What companies does Willett Advisors invest in?
- Willett Advisors has 6 recorded portfolio companies, including Neurona Therapeutics, Cellares, Antares Therapeutics.
- What is Willett Advisors's AUM?
- Willett Advisors manages approximately $25K in assets.